CERS · XBRL financial data

Cerus financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CERS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	114	160	188	187	201	234
Cost of goods and services sold	41	—	—	—	—	—
Selling, general and administrative	67	81	83	76	76	81
Total operating expenses	131	145	147	147	135	149
Operating income (loss)	(58)	(49)	(34)	(30)	(14)	(9)
Interest expense	4	5	6	8	9	8
Other income (expense)	2	0	(2)	2	2	3
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	(60)	(54)	(43)	(37)	(21)	(16)
Earnings per share, basic USD per share	(0.37)	(0.32)	(0.24)	(0.21)	(0.11)	(0.08)
Earnings per share, diluted USD per share	(0.37)	(0.32)	(0.24)	(0.21)	(0.11)	(0.08)
Weighted average shares, basic millions of shares	164	171	177	180	185	191
Weighted average shares, diluted millions of shares	164	171	177	180	185	191

Fiscal years (CERS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	37	49	36	12	20	20
Marketable securities	97	81	67	54	60	63
Accounts receivable	21	25	34	36	30	30
Inventory	23	27	29	40	38	56
Prepaid and other current assets	5	6	5	3	4	5
Total current assets	183	187	170	144	152	174
Property and equipment, net	14	12	11	9	7	9
Right-of-use asset	13	13	13	11	8	10
Goodwill	1	1	1	1	1	1
Total assets	221	237	218	198	201	222
Accounts payable	24	36	33	24	22	28
Accrued liabilities	25	26	25	19	19	25
Total current liabilities	60	79	117	68	64	101
Lease liability, non-current	17	16	15	14	12	10
Total liabilities	118	152	150	144	144	157
Accumulated deficit	(910)	(964)	(1,007)	(1,045)	(1,066)	(1,081)
Total stockholders' equity	104	85	68	53	56	64
Total liabilities and equity	221	237	218	198	201	222
Common shares outstanding (cover page) millions of shares	168	174	178	181	186	192

Fiscal years (CERS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(60)	(54)	(43)	(37)	(21)	(16)
Stock-based compensation	18	24	24	20	23	23
Depreciation and amortization	3	3	3	3	2	1
Net cash from operating activities	(41)	(34)	(26)	(43)	11	5
Purchases of property and equipment	2	1	2	5	3	4
Net cash from investing activities	(50)	13	8	9	(8)	(6)
Proceeds from issuing common stock	77	3	(0)	(0)	(0)	(0)
Proceeds from long-term debt	—	15	—	—	—	—
Net cash from financing activities	92	34	4	11	5	0
Net change in cash	1	12	(14)	(24)	8	(1)

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Cerus	16	58	3*	202.0M	—	Q3 FY26 10-QSep 30, 2026
SANUWAVE Health	9.4	9.7	0.4*	8.6M	—	Q2 FY26 10-QJun 30, 2026
Electromed	20	19*	3*	8.4M	—	Q4 FY26 10-KJun 30, 2026
Tactile Systems Technology	75	92	12*	22.4M	—	Q3 FY26 10-QSep 30, 2026
Orasure Technologies	161	31	(9.9)*	69.0M	16.2 quarters	Q2 FY26 10-QJun 30, 2026
Heartflow	34	64	(8.6)*	87.0M	19.0 quarters	Q2 FY26 10-QJun 30, 2026
Bioventus	31	142	21*	not reported	—	Q3 FY26 10-QSep 26, 2026
Treace Medical Concepts	13	45	(4.7)*	65.0M	9.7 quarters	Q2 FY26 10-QJun 30, 2026
SS Innovations International	14	not reported	(4.2)*	200.4M	3.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.